Marabese, M., Ganzinelli, M., Garassino, M. C., Shepherd, F. A., Piva, S., Caiola, E., . . . Rulli, E. (2015). KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy. Oncotarget.
Chicago-tyylinen lähdeviittausMarabese, Mirko, et al. "KRAS Mutations Affect Prognosis of Non-small-cell Lung Cancer Patients Treated With First-line Platinum Containing Chemotherapy." Oncotarget 2015.
MLA-viiteMarabese, Mirko, et al. "KRAS Mutations Affect Prognosis of Non-small-cell Lung Cancer Patients Treated With First-line Platinum Containing Chemotherapy." Oncotarget 2015.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.